Sort   by:  
 Page size 
TranscriptomicsA 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
To determine the differential expression of KRAS-variant HNSCC (head and neck squamous cell carcinoma) cell lines. Total RNA collected from a panel of HNSCC cell lines.
ORGANISM(S): Homo sapiens 
2014-10-02 | E-GEOD-36110 | biostudies-arrayexpress
UnknownA 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Not available
S-EPMC4207729 | biostudies-literature
TranscriptomicsRegulation of HB-EGF by miR-212 and acquired cetuximab-resistance in head and neck cancer
To determine the mechanism of cetuximab-resistance in head and neck cancer, a cetuximab-sensitive cell line (SCC1) and its cetuximab-resistant derivative (1Cc8) were analyzed for differentially expressed genes using DNA microarrays. 900 differentially expressed genes were found using the statistical...
ORGANISM(S): Homo sapiens 
2011-01-14 | E-GEOD-21483 | biostudies-arrayexpress
UnknownCombined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
Not available
S-EPMC9533323 | biostudies-literature
ProteomicsProteogenomic characterization of human colon and rectal cancer
Explore This Study at the NCI Proteomic Data Commons

Zhang, B., et al., Nature (2014) do...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2019-08-26 | MSV000084238 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 3
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080159 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 9
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080169 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 6
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080162 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 2
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080158 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 1
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080156 | MassIVE
Sort   by:  
 Page size